- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Dina latif
Total 1617 results
-
Massachusetts General HospitalSanofi; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; North...Withdrawn
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical Center; Brigham...CompletedHematologic MalignancyUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Beth Israel Deaconess Medical Center; Brigham...CompletedSquamous Cell Carcinoma | Carcinoma of Head and/or NeckUnited States
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Duke University; H. Lee Moffitt Cancer Center and...Not yet recruitingHematopoietic Stem Cell TransplantUnited States
-
Harvard School of Public Health (HSPH)Boston University; Dana-Farber Cancer Institute; Dimagi Inc.; Narotam Sekhsaria...Not yet recruiting
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsTerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Progressive Breast CancerUnited States
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedRenal Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedLymphoma, Non-Hodgkin | MALT LymphomaUnited States
-
Mary-Ellen Taplin, MDSanofi; Beth Israel Deaconess Medical Center; Genentech, Inc.; Duke UniversityCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer Institute; National Institutes...Recruiting
-
Steven J Isakoff, MD, PhDDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; AbbottActive, not recruitingBreast Cancer | Metastatic Breast Cancer | BRCA1 Gene Mutation | brca2 Gene MutationUnited States
-
Emory UniversityNational Institute of Neurological Disorders and Stroke (NINDS); Hope for Depression... and other collaboratorsActive, not recruitingTreatment Resistant DepressionUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis... and other collaboratorsTerminated
-
University of California, San FranciscoDana-Farber Cancer Institute; UCSF Benioff Children's Hospital Oakland; Alex's...CompletedSarcoma | Refractory SarcomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsTerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Georgetown... and other collaboratorsCompletedProstate Cancer | Adenocarcinoma of ProstateUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Carcinoma of the BreastUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Papillary Serous Mullerian Tumor | Clear Cell Mullerian TumorUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Translational...CompletedBreast NeoplasmsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGastric Cancer | Esophageal Cancer | GE Junction CancerUnited States
-
Ina-RespondNational Institute of Health Research and Development, Ministry of Health...CompletedDepression | HIV/AIDSIndonesia
-
Dana-Farber Cancer InstituteSusan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation; Terri...Active, not recruiting
-
Massachusetts General HospitalDana-Farber Cancer Institute; Boston Children's Hospital; National Institutes... and other collaboratorsActive, not recruitingBone Sarcoma | Non-rhabdomyosarcoma Soft Tissue SarcomaUnited States
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research Institute; National Cancer Institute (NCI); Alliance for Clinical Trials in OncologyCompletedMetastatic Colorectal Cancer | Metastatic Pancreatic Cancer | Unresectable Pancreatic CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital and other collaboratorsCompletedPancreatic Neuroendocrine TumorUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and... and other collaboratorsCompletedEpstein Barr Virus Infections | Post-transplant Lymphoproliferative Disease | Solid Organ Transplant | Stem Cell Transplant (Bone Marrow Transplant)United States
-
Patrick Y. Wen, MDMassachusetts General Hospital; Dana-Farber Cancer Institute; Brigham and Women... and other collaboratorsTerminatedHigh Grade Glioma: Glioblastoma (GBM) | High Grade Glioma: Gliosarcoma | Anaplastic Astrocytoma (AA) | Anaplastic Oligodendroglioma (AO) | Mixed Anaplastic Oligoastrocytoma (AOA)United States
-
Massachusetts General HospitalSanofi; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBiliary Tract Cancer | Gallbladder AdenocarcinomaUnited States
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical... and other collaboratorsCompletedHepatocellular CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteJanssen Pharmaceuticals; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsActive, not recruitingSmoldering Multiple Myeloma | Monoclonal GammopathyUnited States
-
David M. Jackman, MDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Synta Pharmaceuticals...CompletedSmall Cell Lung CancerUnited States
-
David M. Jackman, MDBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-small Cell Lung CancerUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's Hospital; Vanderbilt...CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genzyme,... and other collaboratorsCompletedAcute Lymphoblastic LeukemiaUnited States
-
University Medical Center GroningenComprehensive Cancer Centre The Netherlands; Dutch Cancer Society; Dutch Institute... and other collaboratorsRecruitingThe Aim of This Project is to Develop and Validate NTCP-models for Complications After nCRT (and Surgical Resection)Netherlands
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and... and other collaboratorsCompletedDuctal Breast CancerUnited States
-
Baylor College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedCongenital Heart Disease | Hypoplastic Left Heart Syndrome | Transposition of the Great Arteries | Aortic Arch Hypoplasia or InterruptionUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoDana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of MinnesotaCompletedGraft vs Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaboratorsTerminatedRectal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Emory University; University of... and other collaboratorsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Eli Lilly and Company; Genentech, Inc.; Brigham... and other collaboratorsTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Brigham and Women's HospitalMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedOral Chronic Graft-versus-host DiseaseUnited States
-
Harold J. Burstein, MD, PhDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Celgene...Completed
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaboratorsCompletedNon-small Cell Lung CancerUnited States